Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hui-Hua Hsiao

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
International Journal of Molecular Sciences|November 9, 2018
NRF2 Is One of the Players Involved in Bone Marrow Mediated Drug Resistance in Multiple MyelomaChia-Hung Yen, Hui-Hua Hsiao
American Journal of Clinical Dermatology|May 1, 2014
Mucosal lichen planus: an evidence-based treatment updateParastoo Davari, Hui-Hua Hsiao, Nasim Fazel
Journal of Personalized Medicine|April 30, 2021
Management of Hepatitis B Virus Reactivation in Malignant Lymphoma Prior to Immunosuppressive TreatmentYu-Fen Tsai, Chin-Mu Hsu, Hui-Hua Hsiao
Journal of Personalized Medicine|November 27, 2021
Hepatitis B Virus Infection in Patients Receiving Allogeneic Hematopoietic Stem Cell TransplantationYi-Chang Liu, Chi-Mu Hsu, Samuel Yien Hsiao, et al.
International Journal of Molecular Sciences|September 17, 2020
Pathogenic Mechanisms of Myeloma Bone Disease and Possible Roles for NRF2Chia-Hung Yen, Chin-Mu Hsu, Samuel Yien Hsiao, et al.
International Reviews of Immunology|November 8, 2011
Antigen-specific versus antigen-nonspecific immunotherapeutic approaches for human melanoma: the need for integration for optimal efficacy?Julia K Tietze, Gail D Sckisel, Hui-Hua Hsiao, et al.
Leukemia Research|September 17, 2005
De novo appearance of der(1;7)(q10;p10) is associated with leukemic transformation and unfavorable prognosis in essential thrombocythemiaHui-Hua Hsiao, Yoshikazu Ito, Goro Sashida, et al.
International Journal of Molecular Sciences|April 3, 2021
Management of Myeloma Bone LesionsJeng-Shiun Du, Chia-Hung Yen, Chin-Mu Hsu, et al.
Journal of Immunotoxicology|June 28, 2012
The role of antigen-specific and non-specific immunotherapy in the treatment of cancerArta M Monjazeb, Hui-Hua Hsiao, Gail D Sckisel, et al.
Frontiers in Pharmacology|February 24, 2018
1,2,3,4,6-Penta-<i>O</i>-Galloyl-Beta-D-Glucopyranoside Inhibits Proliferation of Multiple Myeloma Cells Accompanied with Suppression of MYC ExpressionDuurenjargal Tseeleesuren, Rajni Kant, Chia-Hung Yen, et al.
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
International Journal of Molecular Sciences|November 9, 2018
NRF2 Is One of the Players Involved in Bone Marrow Mediated Drug Resistance in Multiple MyelomaChia-Hung Yen, Hui-Hua Hsiao
American Journal of Clinical Dermatology|May 1, 2014
Mucosal lichen planus: an evidence-based treatment updateParastoo Davari, Hui-Hua Hsiao, Nasim Fazel
Journal of Personalized Medicine|April 30, 2021
Management of Hepatitis B Virus Reactivation in Malignant Lymphoma Prior to Immunosuppressive TreatmentYu-Fen Tsai, Chin-Mu Hsu, Hui-Hua Hsiao
Journal of Personalized Medicine|November 27, 2021
Hepatitis B Virus Infection in Patients Receiving Allogeneic Hematopoietic Stem Cell TransplantationYi-Chang Liu, Chi-Mu Hsu, Samuel Yien Hsiao, et al.
International Journal of Molecular Sciences|September 17, 2020
Pathogenic Mechanisms of Myeloma Bone Disease and Possible Roles for NRF2Chia-Hung Yen, Chin-Mu Hsu, Samuel Yien Hsiao, et al.
International Reviews of Immunology|November 8, 2011
Antigen-specific versus antigen-nonspecific immunotherapeutic approaches for human melanoma: the need for integration for optimal efficacy?Julia K Tietze, Gail D Sckisel, Hui-Hua Hsiao, et al.
Leukemia Research|September 17, 2005
De novo appearance of der(1;7)(q10;p10) is associated with leukemic transformation and unfavorable prognosis in essential thrombocythemiaHui-Hua Hsiao, Yoshikazu Ito, Goro Sashida, et al.
International Journal of Molecular Sciences|April 3, 2021
Management of Myeloma Bone LesionsJeng-Shiun Du, Chia-Hung Yen, Chin-Mu Hsu, et al.
Journal of Immunotoxicology|June 28, 2012
The role of antigen-specific and non-specific immunotherapy in the treatment of cancerArta M Monjazeb, Hui-Hua Hsiao, Gail D Sckisel, et al.
Frontiers in Pharmacology|February 24, 2018
1,2,3,4,6-Penta-<i>O</i>-Galloyl-Beta-D-Glucopyranoside Inhibits Proliferation of Multiple Myeloma Cells Accompanied with Suppression of MYC ExpressionDuurenjargal Tseeleesuren, Rajni Kant, Chia-Hung Yen, et al.
Pageof 10